Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 54
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Anticancer Res ; 39(5): 2369-2375, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-31092429

RESUMEN

BACKGROUND/AIM: Benzo[a]pyrene (BaP), an environmental pollutant produced by combustion processes, induces expression of cytochrome P450 (CYP) 1A1 via the activation of aryl hydrocarbon receptor (AHR). Induced CYP1A1 is involved in BaP metabolism, resulting in either detoxification or metabolic activation in a context-dependent manner. The effect of diallyl trisulfide (DATS), a garlic-derived organosulfur compound, on BaP metabolism has not been investigated. MATERIALS AND METHODS: The combined effect of DATS and BaP on BaP metabolism in hepatocyte-derived HepG2 cells was examined. RESULTS: DATS enhanced BaP-induced CYP1A1 and CYP1B1 mRNA expression, BaP hydroxylation and BaP-DNA adduct formation. Combined treatment of BaP and DATS also increased reactive oxygen species levels. DATS enhanced BaP-induced AHR recruitment and histone H3 acetylation on the CYP1A1 promoter. CONCLUSION: DATS combined treatment enhances BaP metabolic activation through an AHR-modulating mechanism.


Asunto(s)
Compuestos Alílicos/farmacología , Benzo(a)pireno/farmacología , Citocromo P-450 CYP1A1/genética , Receptores de Hidrocarburo de Aril/genética , Sulfuros/farmacología , Activación Metabólica/efectos de los fármacos , Compuestos Alílicos/química , Aductos de ADN/efectos de los fármacos , Aductos de ADN/genética , Ajo/química , Regulación de la Expresión Génica/efectos de los fármacos , Células Hep G2 , Humanos , Especies Reactivas de Oxígeno/metabolismo , Sulfuros/química
2.
Integr Cancer Ther ; 18: 1534735419833778, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30841763

RESUMEN

This study aimed to evaluate the effect of lignin-derived polyphenolic composition BP-C3 on the efficacy and hematological toxicity of cyclophosphamide (CPA). Male and female Swiss-H derived mice bearing benzo[a]pyrene-induced soft tissue sarcomas were treated with CPA 300 mg/kg, BP-C3 75 mg/kg, or a combination. Tumor growth inhibition in male mice treated with CPA, BP-C3, or a combination of CPA and BP-C3 was significant and corresponded to 78%, 45%, and 82%, respectively, on day 21 after CPA administration on day 0. In female mice, tumor growth inhibition was 58%, -11%, and 35% when treated with CPA, BP-C3, or a combination of CPA and BP-C3, respectively. CPA administration resulted in significant hematological toxicity evidenced by a decreased white blood cell count on day 4 (2.43 ± 1.77 × 109/L in male mice and 1.19 ± 0.71 × 109/L in female mice) and anemia development on day 7 (6.55 ± 1.74 × 1012/L in male mice and 5.89 ± 2.24 × 1012/L in female mice). The red blood cell count measured on day 7 in animals treated with the combination of BP-C3 and CPA constituted 7.12 ± 1.17 × 1012/L and 7.36 ± 2.07 × 1012/L for male and female mice, respectively. The results of our study demonstrate the antitumor activity of BP-C3 in male mice bearing soft tissue sarcomas. Neither the antitumor activity nor the hematological toxicity of CPA were significantly influenced by BP-C3. A less pronounced effect of CPA on RBC count is demonstrated when this agent is given jointly with BP-C3.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Benzo(a)pireno/farmacología , Ciclofosfamida/efectos adversos , Ciclofosfamida/farmacología , Enfermedades Hematológicas/inducido químicamente , Polifenoles/farmacología , Sarcoma/tratamiento farmacológico , Animales , Femenino , Masculino , Ratones
3.
Nutr Cancer ; 71(3): 508-523, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30857437

RESUMEN

Our understanding of dose-related effects of polymeric black tea polyphenols (PBPs), the most abundant polyphenols in black tea, is limited. In the present study, the effect of various doses of black tea (0.75, 1.5, and 3%)-derived PBP-rich extract on biochemical parameters and lung carcinogenicity in A/J mice was investigated. Pretreatment with PBPs showed the dose-related decrease in B(a)P-induced expression and activity of CYP1A1 in the liver while CYP1A2 expression and activity in the lung. Dose-dependent significant increase in PBP-mediated over-expression and activity of GSTs (alpha in the liver while pi in the lung) were observed in polyphenol-treated groups. Significant dose-related decrease in number and intensity of BPDE-DNA adducts were observed in liver and lung. Black tea (1.5%, 3%)-derived PBPs showed dose-mediated decrease in lung tumor incidence and multiplicity which was further correlated with different molecular markers like cell proliferation and apoptosis in B(a)P and NNK model. In conclusion, dose-dependent chemopreventive effects of PBPs, both anti-initiating (induction of phase II and inhibition of carcinogen-induced phase-I enzymes leading to decrease in BPDE-DNA adducts) and anti-promoting (decreased cell proliferation and increased apoptosis lowering incidence and/or multiplicity of lung lesions), were observed in A/J mice without significant toxicity.


Asunto(s)
Benzo(a)pireno/farmacología , Carcinogénesis/efectos de los fármacos , Neoplasias Pulmonares/prevención & control , Nitrosaminas/farmacología , Polifenoles/administración & dosificación , Té/química , Animales , Anticarcinógenos/administración & dosificación , Camellia sinensis/química , Citocromo P-450 CYP1A1/antagonistas & inhibidores , Inhibidores del Citocromo P-450 CYP1A2/administración & dosificación , Aductos de ADN/análisis , Relación Dosis-Respuesta a Droga , Glutatión Transferasa/efectos de los fármacos , Hígado/enzimología , Pulmón/enzimología , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/patología , Masculino , Ratones , Extractos Vegetales/administración & dosificación
4.
Fish Physiol Biochem ; 44(1): 95-108, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28822029

RESUMEN

In the present study, full-length CYP1A cDNA from Catla catla (Catla) has been identified, and its real-time quantitative reverse transcription PCR (qRT-PCR) expression has been evaluated in different tissues, developmental stages (0, 3, 6, 12 and 24 h and 5, 7 and 9 days post-fertilization) and copper sulphate and benzo(a)pyrene (BaP)-treated 5-day post-fertilization (dpf) larvae (6 to 6.5 mm). Various structural, comparative and phylogenetic analyses of the deduced amino acid sequence revealed that the identified gene of Catla belongs to the CYP1A1 subfamily. Among different tissues of Catla, the highest CYP1A expression was observed in the kidney followed by the liver, muscle, gill, intestine and brain. CYP1A mRNA expression was detected during all the larval developmental stages, including the unfertilized egg with the highest expression on 9 dpf. BaP (3.5 ppb) and copper sulphate (sublethal dose 0.516 ppm) challenge test for 96 h to Catla larvae revealed the highest CYP1A1 expression at 48 h post-challenge. CYP1A1 transcript also showed a concentration-dependent increase in expression following exposure at 1.75 and 3.5 ppb of BaP for 48 h. Its expression profiling indicates that it is functional at early developmental stages. It can also be used to develop a specific biomarker tool for monitoring environmental pollution.


Asunto(s)
Benzo(a)pireno/farmacología , Sulfato de Cobre/farmacología , Cipriniformes/genética , Citocromo P-450 CYP1A1/genética , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Clonación Molecular , Cipriniformes/crecimiento & desarrollo , Citocromo P-450 CYP1A1/metabolismo , ADN Complementario/genética , ADN Complementario/metabolismo , Larva/genética , Larva/metabolismo , Modelos Moleculares , Filogenia , Conformación Proteica
5.
Neuropeptides ; 61: 23-30, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27402563

RESUMEN

Environmental neurotoxicant like benzo[a]pyrene (B[a]P) is known to induce neurobehavioral changes. Our previous reports address the adverse effect of B[a]P on the neurobehavioral responses and neuromorphology of sensitive brain regions in adolescent rats. Present study was conducted on male Wistar rat neonates at postnatal day 5 (PND5) to ascertain B[a]P induced anxiolytic like behavioral response could be an outcome of neuropeptide Y (NPY) overexpression in brain. Single intracisternal administration of B[a]P was carried out at PND5 to elucidate the role of NPY on neurobehavioral responses at PND30. The behavioral studies showed anxiolytic like effect of B[a]P in both light and dark box and elevated plus maze tests. Antioxidant assay involving glutathione peroxidase activity was significantly decreased where as lipid peroxidation was significantly augmented in both hippocampus and hypothalamus of B[a]P treated group as compared to naive and control. The neurotransmitter estimation by HPLC-ECD showed significant increase in 5-HT level in both hippocampus and hypothalamus of B[a]P treated group. Significant elevation in NPY expression was observed in both hippocampus and hypothalamus of B[a]P group. Intracellular Ca2+ estimation using Fura-2AM by fluorometry showed that B[a]P induced increase in Ca2+ influx was associated with augmented NPY expression in brain. As NPY has orexigenic effect, our result revealed that there was a significant increase in body weight at PND30 following B[a]P administration to rat neonates at PND5. These findings suggested that NPY overexpression in brain regions might be associated with anxiolytic like behavioral response and orexigenic effect in rats following single intracisternal B[a]P administration. Future research directing towards understanding the signaling cascades of B[a]P induced biochemical and neuromorphological alteration might address the independent pathway which induce neurodegeneration despite NPY overexpression in brain regions of adolescent rats.


Asunto(s)
Conducta Animal/efectos de los fármacos , Benzo(a)pireno/farmacología , Hipocampo/efectos de los fármacos , Hipotálamo/efectos de los fármacos , Neuropéptido Y/metabolismo , Animales , Ansiolíticos/farmacología , Conducta Animal/fisiología , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Hipocampo/metabolismo , Hipotálamo/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Ratas , Ratas Wistar , Maduración Sexual/fisiología
6.
Pharmacol Rep ; 68(2): 310-8, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26922533

RESUMEN

BACKGROUND: Chemoprevention is considered as one of the most promising and realistic approaches in the prevention of lung cancer. Chrysin, a naturally occurring dietary flavone widely found in Passiflora family of plants and honey, has been studied extensively for its chemopreventive properties. The objective of present study is to divulge the chemopreventive role of chrysin against benzo(a)pyrene [B(a)P] induced lung carcinogenesis in Swiss albino mice. METHODS: B(a)P was administered orally (50mg/kg body weight) twice a week for four weeks to induce lung cancer in mice. The body weight, lung weight, tumor incidence, lipid peroxidation, carcinoembryonic antigen, enzymatic antioxidants (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase) and non-enzymatic antioxidants (reduced glutathione, vitamin E and vitamin C) were estimated. Further, histopathological analysis of lung tissue and western blotting analysis of PCNA, COX-2 and NF-κB were also carried out. RESULTS: Administration of B(a)P resulted in increased lipid peroxides and carcinoembryonic antigen with concomitant decrease in the levels of both enzymatic antioxidants and non-enzymatic antioxidants. Chrysin treatment (250mg/kg body weight) significantly attenuated all these changes thereby showing potent anti lung cancer effect. Further, the anticancer effect of chrysin was confirmed by histopathology of lungs, and immunoblotting analysis of PCNA, COX-2 and NF-κB, where chrysin supplementation downregulated the expression of these proteins and maintained cellular homeostasis. CONCLUSION: Overall, these findings confirm the chemopreventive potential of chrysin against B(a)P induced lung cancer in Swiss albino mice.


Asunto(s)
Benzo(a)pireno/farmacología , Carcinogénesis/efectos de los fármacos , Flavonas/farmacología , Flavonoides/farmacología , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/tratamiento farmacológico , Pulmón/efectos de los fármacos , Animales , Anticarcinógenos/farmacología , Antioxidantes/metabolismo , Ácido Ascórbico/metabolismo , Catalasa/metabolismo , Quimioprevención/métodos , Dieta/métodos , Modelos Animales de Enfermedad , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Pulmón/metabolismo , Neoplasias Pulmonares/metabolismo , Masculino , Ratones , FN-kappa B/metabolismo , Superóxido Dismutasa/metabolismo , Vitamina E/metabolismo
7.
Pharmacol Rep ; 68(2): 319-28, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26922534

RESUMEN

BACKGROUND: Chronic airway inflammation is coordinated by a complex of inflammatory mediators, including eicosanoids. The aim of this study was to evaluate the impact of polycyclic aromatic hydrocarbons (PAHs) on the human lung epithelial carcinoma A549 cells supplemented with docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids. METHODS: We analyzed the influence of DHA, EPA and/or benzo(a)pyrene (BaP), chrysene (Chr), fluoranthene (Flu) and benzo(a)anthracene (Baa) treatment on the fatty acids (FAs) profile and the formation of isoprostanes. We studied the cyclooxygenase-2, FP-receptor, peroxisome proliferator-activated receptors PPARδ and PPARγ, transcription factor NF-кB p50 and p65 expression by Western blot, phospholipase A2 (cPLA2) activity, as well as aryl hydrocarbon receptor (AHR), cytochrome P450 (CYP1A1), phospholipase A2 (PLA2G4A) and prostaglandin synthase 2 (PTGS2) gene expression by qRT-PCR. RESULTS: DHA or EPA supplementation and BaP or Baa treatment resulted in a higher level of PGF3α. COX-2 expression was decreased while PPARδ expression and cPLA2 activity was increased after fatty acid supplementation and PAHs treatment. DHA and EPA up-regulated AHR and PLA2G4A genes. CONCLUSIONS: Supplementation with n-3 FAs resulted in changes of inflammatory-state related genes in the lung epithelial cells exposed to PAHs. The altered profile of lipid mediators from n-3 FA as well as repression of the COX-2 protein by n-3 PUFAs in A549 cells incubated with PAHs suggests anti-inflammatory and pro-resolving properties of DHA and EPA. It remains to be shown whether these pleiotropic and protective actions of n-3 FAs contribute to fish oil's therapeutic effect in asthma.


Asunto(s)
Células Epiteliales/efectos de los fármacos , Ácidos Grasos Omega-3/farmacología , Inflamación/genética , Pulmón/efectos de los fármacos , Hidrocarburos Policíclicos Aromáticos/farmacología , Células A549 , Benzo(a)pireno/farmacología , Línea Celular Tumoral , Crisenos/farmacología , Ciclooxigenasa 2/metabolismo , Citocromo P-450 CYP1A1/metabolismo , Ácidos Docosahexaenoicos/farmacología , Ácido Eicosapentaenoico/farmacología , Células Epiteliales/metabolismo , Fluorenos/farmacología , Expresión Génica/efectos de los fármacos , Fosfolipasas A2 Grupo IV/metabolismo , Humanos , Pulmón/metabolismo , FN-kappa B/metabolismo , PPAR gamma/metabolismo , Prostaglandinas F/metabolismo , Receptores de Hidrocarburo de Aril/metabolismo
8.
Bioinformatics ; 31(13): 2115-22, 2015 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-25701576

RESUMEN

MOTIVATION: Comparing time courses of gene expression with time courses of phenotypic data may provide new insights in cellular mechanisms. In this study, we compared the performance of five pattern recognition methods with respect to their ability to relate genes and phenotypic data: one classical method (k-means) and four methods especially developed for time series [Short Time-series Expression Miner (STEM), Linear Mixed Model mixtures, Dynamic Time Warping for -Omics and linear modeling with R/Bioconductor limma package]. The methods were evaluated using data available from toxicological studies that had the aim to relate gene expression with phenotypic endpoints (i.e. to develop biomarkers for adverse outcomes). Additionally, technical aspects (influence of noise, number of time points and number of replicates) were evaluated on simulated data. RESULTS: None of the methods outperforms the others in terms of biology. Linear modeling with limma is mostly influenced by noise. STEM is mostly influenced by the number of biological replicates in the dataset, whereas k-means and linear modeling with limma are mostly influenced by the number of time points. In most cases, the results of the methods complement each other. We therefore provide recommendations to integrate the five methods. AVAILABILITY: The Matlab code for the simulations performed in this research is available in the Supplementary Data (Word file). The microarray data analysed in this paper are available at ArrayExpress (E-TOXM-22 and E-TOXM-23) and Gene Expression Omnibus (GSE39291). The phenotypic data are available in the Supplementary Data (Excel file). Links to the pattern recognition tools compared in this paper are provided in the main text. CONTACT: d.hendrickx@maastrichtuniversity.nl SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.


Asunto(s)
Perfilación de la Expresión Génica/métodos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Reconocimiento de Normas Patrones Automatizadas/métodos , Programas Informáticos , Antifibrinolíticos/farmacología , Benzo(a)pireno/farmacología , Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/genética , Simulación por Computador , Humanos , Modelos Lineales , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/genética , Fenotipo , Factores de Tiempo , Vitamina K 3/farmacología
9.
Biomed Res Int ; 2014: 467465, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24949451

RESUMEN

Punicalagin (PC) is an ellagitannin found in the fruit peel of Punica granatum. We have demonstrated antioxidant and antigenotoxic properties of Punica granatum and showed that PC and ellagic acid (EA) are its major constituents. In this study, we demonstrate the antimutagenic potential, inhibition of BP-induced DNA damage, and antiproliferative activity of PC and EA. Incubation of BP with rat liver microsomes, appropriate cofactors, and DNA in the presence of vehicle or PC and EA showed significant inhibition of the resultant DNA adducts, with essentially complete inhibition (97%) at 40 µ M by PC and 77% inhibition by EA. Antimutagenicity was tested by Ames test. PC and EA dose-dependently and markedly antagonized the effect of tested mutagens, sodium azide, methyl methanesulfonate, benzo[a]pyrene, and 2-aminoflourine, with maximum inhibition of mutagenicity up to 90 percent. Almost all the doses tested (50-500 µ M) exhibited significant antimutagenicity. A profound antiproliferative effect on human lung cancer cells was also shown with PC and EA. Together, our data show that PC and EA are pomegranate bioactives responsible for inhibition of BP-induced DNA adducts and strong antimutagenic, antiproliferative activities. However, these compounds are to be evaluated in suitable animal model to assess their therapeutic efficacy against cancer.


Asunto(s)
Aductos de ADN/efectos de los fármacos , Ácido Elágico/administración & dosificación , Taninos Hidrolizables/administración & dosificación , Extractos Vegetales/administración & dosificación , Animales , Antioxidantes/administración & dosificación , Benzo(a)pireno/farmacología , Daño del ADN/efectos de los fármacos , Ácido Elágico/química , Humanos , Taninos Hidrolizables/química , Lythraceae/química , Mutagénesis/efectos de los fármacos , Extractos Vegetales/química , Ratas , Salmonella typhimurium/efectos de los fármacos
10.
Neuro Endocrinol Lett ; 34 Suppl 2: 43-54, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24362092

RESUMEN

OBJECTIVES: The aim of this study was to investigate a role of cytochrome P450 (CYP) and peroxidase in ellipticine oxidative activation in two mouse strains differing in expression of NADPH:CYP reductase (POR) [the HRN (Hepatic Cytochrome P450 Reductase Null) mice, in which POR is deleted in hepatocytes and its wild-type (WT) counterpart], and in levels of CYP1A1/2 and cytochrome b5 that were modulated by treatment of these mouse models with a CYP1A inducer, benzo[a]pyrene (BaP). METHODS: Ellipticine-DNA adducts were detected by 32P-postlabeling. HPLC was employed for the separation and characterization of ellipticine metabolites. RESULTS: Hepatic microsomes of HRN and WT mice activate ellipticine to form ellipticine-derived DNA adducts. A 2.2- and 10.4-fold increase in amounts of ellipticine-derived DNA adducts formed by liver microsomes was caused by exposure of HRN and WT mice to BaP, respectively. The results found and utilization of NADPH and arachidonic acid, cofactors of CYP- and cyclooxygenase (COX)-dependent enzyme systems, respectively, as well as inhibitors of CYP1A1/2 and 3A, demonstrate that the CYP1A and 3A enzymes play a major role in ellipticine activation in liver microsomes. In addition, the COX enzyme is important in ellipticine activation in liver of HRN mice. CONCLUSION: The CYP1A and 3A enzymes activate ellipticine mainly in liver of WT mice, whereas peroxidase COX plays this role in liver of HRN mice. Treatment of mice with BaP increases an impact of CYP1A on ellipticine activation. A pattern of expression levels of these enzymes plays a crucial role in their impact on this process.


Asunto(s)
Antineoplásicos/farmacocinética , Benzo(a)pireno/farmacología , Elipticinas/farmacocinética , Animales , Biotransformación/efectos de los fármacos , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP1A2/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Evaluación Preclínica de Medicamentos , Interacciones Farmacológicas , Femenino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/metabolismo
11.
Biomed Res Int ; 2013: 627907, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23984390

RESUMEN

Studies have found that biotin favors glucose and lipid metabolism, and medications containing biotin have been developed. Despite the use of biotin as a pharmacological agent, few studies have addressed toxicity aspects including the possible interaction with cytochrome P450 enzyme family. This study analyzed the effects of pharmacological doses of biotin on the expression and activity of the cytochrome P4501A subfamily involved in the metabolism of xenobiotics. Wistar rats were treated daily with biotin (2 mg/kg, i.p.), while the control groups were treated with saline. All of the rats were sacrificed by cervical dislocation after 1, 3, 5, or 7 days of treatment. CYP1A1 and CYP1A2 mRNAs were modified by biotin while enzyme activity and protein concentration were not affected. The lack of an effect of biotin on CYP1A activity was confirmed using other experimental strategies, including (i) cotreatment of the animals with biotin and a known CYP1A inducer; (ii) the addition of biotin to the reaction mixtures for the measurement of CYP1A1 and CYP1A2 activities; and (iii) the use of an S9 mixture that was prepared from control and biotin-treated rats to analyze the activation of benzo[a]pyrene (BaP) into mutagenic metabolites using the Ames test. The results suggest that biotin does not influence the CYP1A-mediated metabolism of xenobiotics.


Asunto(s)
Biotina/farmacología , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP1A2/metabolismo , Suplementos Dietéticos , Animales , Benzo(a)pireno/farmacología , Biocatálisis/efectos de los fármacos , Citocromo P-450 CYP1A1/biosíntesis , Citocromo P-450 CYP1A1/genética , Citocromo P-450 CYP1A2/biosíntesis , Citocromo P-450 CYP1A2/genética , Inducción Enzimática/efectos de los fármacos , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , MicroARNs/genética , MicroARNs/metabolismo , Pruebas de Mutagenicidad , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar
12.
Artículo en Inglés | MEDLINE | ID: mdl-23159325

RESUMEN

Scinderin like (ScinL) gene is a unique gelsolin family gene found only in fish. In this study ScinL gene was cloned in olive flounder for the first time and characterized its expression and function. Flounder ScinL cDNA consists of 2911 nucleotides encoding a putative protein of 720 amino acids (79.4 kDa). In phylogenetic analysis, flounder ScinL is closely related to ScinL of zebra fish, anableps, and fugu with the similarity of 51-72%. Fish ScinLs are positioned between gelsolin and scinderin of other species. Flounder ScinL protein has the highly conserved actin and PIP2 binding sites, Ca(2+) coordination site, and a C-terminal latch helix preventing the activation of ScinL protein in the absence of Ca(2+). Putative binding sites for NFAT and AP-1 were found in 5' flanking region. Constitutive ScinL expression was found in most organs and the expression level was higher in gill, head kidney, trunk kidney, spleen and skin than muscle, stomach, intestine and brain. In Q-PCR analysis ScinL and CYP1A1 gene expression were significantly upregulated by BaP in head kidney in vivo and in vitro, and in macrophage cells. Upregulated ScinL expression by BaP was blocked by EGTA, indicating a calcium dependent regulation of ScinL expression.


Asunto(s)
Proteínas de Peces/genética , Lenguado/genética , Gelsolina/genética , Perfilación de la Expresión Génica , Región de Flanqueo 5'/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Benzo(a)pireno/farmacología , Sitios de Unión/genética , Calcio/metabolismo , Quelantes/farmacología , Clonación Molecular , ADN Complementario/química , ADN Complementario/genética , Ácido Egtácico/farmacología , Gelsolina/clasificación , Regulación de la Expresión Génica/efectos de los fármacos , Branquias/metabolismo , Riñón Cefálico/efectos de los fármacos , Riñón Cefálico/metabolismo , Datos de Secuencia Molecular , Filogenia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Bazo/metabolismo
13.
Artículo en Inglés | MEDLINE | ID: mdl-22507668

RESUMEN

In order to gain insights into the mechanism of sex steroid signaling in molluscs, the full-length cDNA of estrogen receptor (ER) was isolated and characterized from Chlamys farreri for the first time. The positions of cysteine residues and other residues around them that constitute the two zinc finger motifs and the P-box are conserved. Phylogenetic analysis revealed that the CfER is an ortholog of the other mollusk ERs. Tissue distribution analysis of the CfER mRNA revealed that the expression of ER mRNA was observed in various tissues, and highest in the gonad of males and females. C. farreri were exposed for 10 days to endocrine disrupting chemicals including Benzo(a)pyrene (B(a)p) and polybrominated diphenyl ethers (BDE-47). B(a)p exposure at 0.4 and 2 µg/L caused significant increase in mRNA expression of ER and VTG, but B(a)p at 10 µg/L down-regulated CfER and VTG mRNA expression compared to control. Varying increase of ER and VTG mRNA transcripts was resulted in by BDE-47 at 0.1, 1 and 10 µg/L. These results elucidate potential roles of CfER induced by xenobiotics in C. farreri and can be helpful for investigating the mechanism of sex steroid signaling in bivalve mollusks.


Asunto(s)
Disruptores Endocrinos/farmacología , Pectinidae/efectos de los fármacos , Pectinidae/genética , Receptores de Estrógenos/genética , Receptores de Estrógenos/metabolismo , Secuencia de Aminoácidos , Animales , Benzo(a)pireno/farmacología , Clonación Molecular/métodos , ADN Complementario/genética , Femenino , Expresión Génica/efectos de los fármacos , Perfilación de la Expresión Génica/métodos , Éteres Difenilos Halogenados , Masculino , Datos de Secuencia Molecular , Pectinidae/metabolismo , Filogenia , Bifenilos Polibrominados/farmacología , ARN Mensajero/genética , Alineación de Secuencia/métodos , Distribución Tisular , Dedos de Zinc/genética
14.
Nutr Cancer ; 64(2): 300-6, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22243054

RESUMEN

In the current investigation, the ameliorative effect of green tea (GT) and white tea (WT) against benzo(a)pyrene (BaP) induced oxidative stress and DNA damage has been studied in the livers and lungs of Balb/c mice. A single dose of BaP (125 mg/kg, b.w. orally) increased the levels of lipid peroxidation (LPO) and decreased endogenous antioxidants such as superoxide dismutase (SOD), glutahione reductase (GR), catalase (CAT), and glutathione (GSH) significantly. Pretreatment with GT and WT for 35 days before a single dose of BaP elevated the decreased activity of GR, SOD, and CAT in liver tissue and also tended to normalize the levels of GSH and LPO in both hepatic and pulmonary tissues. The percentage of DNA in comet tail and 8-hydroxy-2'-deoxyguanosine levels reflected the decreasing pattern of DNA damage from the BaP-treated group to the groups that received pretreatment with GT and WT. Our study concludes that both GT and WT are effective in combating BaP induced oxidative insult and DNA damage. However, WT was found to be more protective than GT with respect to CAT (only in the liver), percentage of DNA in comet tail (only in the lungs), GST activity, and GSH content in both the tissues.


Asunto(s)
Benzo(a)pireno/farmacología , Daño del ADN/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Antioxidantes/análisis , Catalasa/análisis , ADN/análisis , Desoxiguanosina/análogos & derivados , Desoxiguanosina/análisis , Glutatión/análisis , Glutatión Reductasa/análisis , Peroxidación de Lípido/efectos de los fármacos , Hígado/química , Hígado/metabolismo , Pulmón/química , Pulmón/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Superóxido Dismutasa/análisis
15.
Asian Pac J Trop Biomed ; 2(2): 109-17, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23569879

RESUMEN

OBJECTIVE: To identify the available phytochemicals and carotenoids in the selected green algae and evaluate the potential genotoxic/antigenotoxic effect using lymphocytes. METHODS: Organic solvent extracts of Chlorococcum humicola (C. humicola) were used for the phytochemical analysis. The available carotenoids were assessed by HPLC, and LC-MS analysis. The genotoxicity was induced by the benzo(a)pyrene in the lymphocyte culture, the genotoxic and antigenotoxic effects of algal carotenoids with and without genotoxic inducer were evaluated by chromosomal aberration (CA), sister chromatid exchange (SCE) and micronucleus assay (MN). RESULTS: The results of the analysis showed that the algae were rich in carotenoids and fatty acids. In the total carotenoids lutein, ß-carotene and α-carotene were found to be present in higher concentration. The frequency of CA and SCE increased by benzo(a)pyrene were significantly decreased by the carotenoids (P<0.05 for CA, P<0.001 for SCE). The MN frequencies of the cells were significantly decreased by the treatment with carotenoids when compared with the positive controls (P<0.05). CONCLUSIONS: The findings of the present study demonstrate that, the green algae C. humicola is a rich source of bioactive compounds especially carotenoids which effectively fight against environmental genotoxic agents, the carotenoids itself is not a genotoxic substance and should be further considered for its beneficial effects.


Asunto(s)
Benzo(a)pireno/farmacología , Carotenoides/farmacología , Aberraciones Cromosómicas/efectos de los fármacos , Daño del ADN/efectos de los fármacos , Linfocitos/efectos de los fármacos , Benzo(a)pireno/efectos adversos , Carotenoides/aislamiento & purificación , Células Cultivadas , Cromatografía Liquida , Aberraciones Cromosómicas/inducido químicamente , Humanos , Espectrometría de Masas , Pruebas de Micronúcleos , Índice Mitótico , Fitoquímicos/farmacología , Extractos Vegetales/farmacología , Intercambio de Cromátides Hermanas/efectos de los fármacos , Volvocida
16.
Immunopharmacol Immunotoxicol ; 34(2): 317-25, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22066884

RESUMEN

Chemoprevention is regarded as one of the most promising and realistic approaches in the prevention of cancer. All-trans retinoic acid (ATRA) is an active metabolite of vitamin A under the family retinoids, derived by irreversible oxidation of retinol (vitamin A), the parent compound for all natural retinoids. The aim of the present study is to divulge the chemopreventive and chemoprotective nature of ATRA during benzo(a)pyrene (B(a)P) induced lung cancer development in BALB/c mice. Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lipid hydroperoxides (LOOH) and nitric oxide (NO) with concomitant decrease in the levels of tissue anti-oxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH) and vitamin C. ATRA supplementation (0.585 mg/kg body weight) attenuated all these alterations, which indicates the anti-cancer effect that was further confirmed by histopathological analysis. Overall, the above data show that the anti-cancer effect of ATRA is more pronounced when used as an chemopreventive agent against B(a)P-induced lung carcinogenesis.


Asunto(s)
Neoplasias Pulmonares/prevención & control , Estrés Oxidativo/efectos de los fármacos , Tretinoina/uso terapéutico , Animales , Ácido Ascórbico/metabolismo , Conducta Animal/efectos de los fármacos , Benzo(a)pireno/administración & dosificación , Benzo(a)pireno/farmacología , Catalasa/metabolismo , Quimioprevención/métodos , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Peróxidos Lipídicos/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Pulmón/patología , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Ratones , Ratones Endogámicos BALB C , Metástasis de la Neoplasia/patología , Metástasis de la Neoplasia/prevención & control , Óxido Nítrico/sangre , Superóxido Dismutasa/metabolismo , Resultado del Tratamiento , Tretinoina/administración & dosificación , Tretinoina/efectos adversos , Tretinoina/farmacología
17.
Environ Toxicol Pharmacol ; 32(2): 296-305, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21843811

RESUMEN

In the present study the chemopreventive effects of water soluble AquaROX(®) 15 and oil soluble VivOX(®) 40 rosemary extracts against 4-nitroquinoline-N-oxide (NQNO) and 2-amino-3-methyl-3H-imidazo[4,5-F]quinoline (IQ) induced mutagenicity in the reverse mutation assays with Salmonella typhimurium TA98 and against t-butyl hydroperoxide (t-BOOH), benzo(a)pyrene (BaP) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced DNA damage in HepG2 cells were studied, applying the comet assay. The results showed comparable protective effect of AquaROX and VivOX against oxidative DNA damage, whereas protection against indirect active genotoxic carcinogens was more efficient by VivOX.


Asunto(s)
Antioxidantes/farmacología , Citoprotección , Células Hep G2/efectos de los fármacos , Extractos Vegetales/farmacología , Rosmarinus/química , Salmonella typhimurium/efectos de los fármacos , 4-Nitroquinolina-1-Óxido/farmacología , Animales , Antioxidantes/química , Benzo(a)pireno/farmacología , Daño del ADN/efectos de los fármacos , Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Humanos , Imidazoles/farmacología , Pruebas de Sensibilidad Microbiana , Pruebas de Mutagenicidad , Mutágenos/farmacología , Oxidación-Reducción , Estrés Oxidativo , Extractos Vegetales/química , Quinolinas/farmacología , Salmonella typhimurium/genética , terc-Butilhidroperóxido/farmacología
18.
J Ethnopharmacol ; 122(1): 136-42, 2009 Feb 25.
Artículo en Inglés | MEDLINE | ID: mdl-19146933

RESUMEN

AIM OF THE STUDY: Although traditional herbal medicines are widely used in Ethiopia, no information is available on their potential genotoxicity. In the present study, hydroalcoholic extracts of Glinus lotoides, Plumbago zeylanica, Rumex steudelii and Thymus schimperi were evaluated for their DNA damaging effects using the comet assay. MATERIAL AND METHODS: Mouse lymphoma L5178Y cells were exposed to different concentrations of the extracts for 3h with and without metabolic activation (S9-mix) using 4-nitroquinoline-N-oxide and benzo(a)pyrene as positive controls, and vehicles as negative controls. RESULTS: In the absence of S9, all extracts were found to induce significant DNA damage without affecting the cell viability. T. schimperi and R. steudelii were the most potent DNA-damaging extracts, and G. lotoides and P. zeylanica the least potent. The addition of S9 had different effects on the DNA damage induced by the extracts: it lowered the DNA damaging effect of P. zeylanica, did not affect the DNA damaging effect of T. schimperi, and increased the DNA damaging effects of R. steudelii and G. lotoides. CONCLUSION: The findings of the present study suggest that all extracts evaluated have a genotoxic potential in vitro which needs to be substantiated by further studies.


Asunto(s)
Supervivencia Celular/efectos de los fármacos , Daño del ADN , Magnoliopsida , Mutágenos/toxicidad , Extractos Vegetales/toxicidad , 4-Nitroquinolina-1-Óxido/farmacología , Animales , Benzo(a)pireno/farmacología , Línea Celular , Relación Dosis-Respuesta a Droga , Etiopía , Linfoma/patología , Medicinas Tradicionales Africanas , Ratones , Molluginaceae , Pruebas de Mutagenicidad , Extractos Vegetales/química , Plumbaginaceae , Rumex , Thymus (Planta)
19.
Biol Pharm Bull ; 30(12): 2268-73, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18057710

RESUMEN

Chemoprevention has emerged as a very effective preventive measure against carcinogenesis. Several bioactive compounds present in fruits and vegetables have revealed their cancer curative potential on benzo(a)pyrene (B(a)P) induced carcinogenesis. In the present study, the efficacy of quercetin on the level of lipid peroxides, activities of antioxidant enzymes and tumor marker enzymes in B(a)P induced experimental lung carcinogenesis in Swiss albino mice was assessed. In lung cancer bearing animals there was an increase in lung weight, lipid peroxidation and marker enzymes such as aryl hydrocarbon hydroxylase, gamma glutamyl transpeptidase, 5'-nucleotidase, lactate dehydrogenase and adenosine deaminase with subsequent decrease in body weight and antioxidant enzymes-superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase, glutathione reductase, reduced glutathione, vitamin E and vitamin C. Quercetin supplementation (25 mg/kg body weight) attenuated all these alterations, which indicates the anticancer effect that was further confirmed by histopathological analysis. Overall, the above data shows that the anticancer effect of quercetin is more pronounced when used as an chemopreventive agent rather than as a chemotherapeutic agent against B(a)P induced lung carcinogenesis.


Asunto(s)
Antioxidantes/metabolismo , Benzo(a)pireno/farmacología , Biomarcadores de Tumor/metabolismo , Carcinógenos/farmacología , Pulmón/metabolismo , Quercetina/farmacología , 5'-Nucleotidasa/sangre , 5'-Nucleotidasa/metabolismo , Adenosina Desaminasa/sangre , Adenosina Desaminasa/metabolismo , Animales , Hidrocarburo de Aril Hidroxilasas/sangre , Hidrocarburo de Aril Hidroxilasas/metabolismo , Biomarcadores de Tumor/sangre , Peso Corporal/efectos de los fármacos , L-Lactato Deshidrogenasa/sangre , L-Lactato Deshidrogenasa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Pulmón/efectos de los fármacos , Pulmón/patología , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/prevención & control , Masculino , Ratones , Tamaño de los Órganos/efectos de los fármacos , gamma-Glutamiltransferasa/sangre , gamma-Glutamiltransferasa/metabolismo
20.
J Med Food ; 10(2): 244-51, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17651059

RESUMEN

Anthocyanins, belonging to the flavonoid family of phytochemicals, have received attention as agents that may have potential in preventing chronic diseases such as cardiovascular diseases and certain cancers. In the present study, an anthocyanin-rich extract from Concord grapes [referred to as Concord grape extract (CGE)] and the anthocyanin delphinidin were evaluated for their capacity to inhibit DNA adduct formation due to the environmental carcinogen benzo[a]pyrene (BP) in MCF-10F cells, a noncancerous, immortalized human breast epithelial cell line. CGE at 10 and 20 microg/mL and delphinidin at 0.6 microM concentrations significantly inhibited BP-DNA adduct formation. This was associated with a significant increase in activities of the phase II detoxification enzymes glutathione S-transferase and NAD(P)H:quinone reductase 1. In addition, these grape components also suppressed reactive oxygen species (ROS) formation, but did not induce antioxidant response element-dependent transcription. Taken together, these data suggest that CGE and a component grape anthocyanin have breast cancer chemopreventive potential due in part to their capacity to block carcinogen-DNA adduct formation, modulate activities of carcinogen-metabolizing enzymes, and suppress ROS in these noncancerous human breast cells.


Asunto(s)
Antocianinas/análisis , Mama/efectos de los fármacos , Daño del ADN/efectos de los fármacos , Frutas/química , Extractos Vegetales/farmacología , Vitis/química , Antocianinas/administración & dosificación , Antocianinas/farmacología , Benzo(a)pireno/farmacología , Mama/metabolismo , Neoplasias de la Mama/prevención & control , División Celular/efectos de los fármacos , Línea Celular Transformada , Citocromo P-450 CYP1A1/metabolismo , Aductos de ADN/metabolismo , Glutatión Transferasa/metabolismo , Humanos , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA